161 related articles for article (PubMed ID: 22460811)
21. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
23. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
Ashton-Sager A; Paulino AF; Afify AM
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
[TBL] [Abstract][Full Text] [Related]
24. Can Nup88 expression be associated with atypical endometrial hyperplasia and endometrial cancer? A preliminary study.
Li Y; Zhang X; Ge J; Liu X; Xu S; Zhu Z; Fang G; Liu J; Zhang H; Sun X
Pathol Res Pract; 2016 Apr; 212(4):274-8. PubMed ID: 26839161
[TBL] [Abstract][Full Text] [Related]
25. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
26. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
[TBL] [Abstract][Full Text] [Related]
27. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
28. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
[TBL] [Abstract][Full Text] [Related]
29. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance.
Niu HL; Pasha TL; Pawel BR; LiVolsi VA; Zhang PJ
Int J Gynecol Pathol; 2009 Jul; 28(4):301-7. PubMed ID: 19483637
[TBL] [Abstract][Full Text] [Related]
30. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
31. Tenascin expression in normal, hyperplastic, and neoplastic endometrium.
Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF
Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226
[TBL] [Abstract][Full Text] [Related]
32. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
33. Significance of hormone receptor status and tumor vessels in normal, hyperplastic and neoplastic endometrium.
Nunobiki O; Taniguchi E; Ishii A; Tang W; Utsunomiya H; Nakamura Y; Mori I; Kakudo K
Pathol Int; 2003 Dec; 53(12):846-52. PubMed ID: 14629750
[TBL] [Abstract][Full Text] [Related]
34. Stromal p16 expression is significantly increased in endometrial carcinoma.
Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
[TBL] [Abstract][Full Text] [Related]
35. Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma.
Flannery CA; Saleh FL; Choe GH; Selen DJ; Kodaman PH; Kliman HJ; Wood TL; Taylor HS
J Clin Endocrinol Metab; 2016 Jul; 101(7):2883-91. PubMed ID: 27088794
[TBL] [Abstract][Full Text] [Related]
36. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
37. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
38. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
39. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
[TBL] [Abstract][Full Text] [Related]
40. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Allison KH; Upson K; Reed SD; Jordan CD; Newton KM; Doherty J; Swisher EM; Garcia RL
Int J Gynecol Pathol; 2012 Mar; 31(2):151-159. PubMed ID: 22317873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
